Clinical Trial

Trial Protocol ID USOR 22244_IM048022

Trial Description

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jose Méndoza, M.D.

Disease Types

Sponsor

  • Bristol-Myers Squibb

ClinicalTrials.gov NCT ID

  • NCT05827016